Dave Puente

January 13, 2022

First Myeloma Center Patient Receives Revolutionary New Therapy, Responds Well

Linda Haymes

Dave and Lori Puente of Elk Grove, California. Dave Puente is the first myeloma patient in Arkansas to receive new chimeric antigen receptor (CAR) T-cell immunotherapy treatment, which is only available at the UAMS Myeloma Center in the Winthrop P. Rockefeller Cancer Institute.

Dave Puente of Elk Grove, California, became the first myeloma patient in Arkansas to receive the new chimeric antigen receptor (CAR) T-cell immunotherapy at the University of Arkansas for Medical Sciences (UAMS) Myeloma Center, the only medical facility in Arkansas currently offering the cutting-edge treatment.